Posttraumatic Stress Disorder (PTSD): Clinical Trials

15 trials for Posttraumatic Stress Disorder (PTSD), newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 completed, 4 not yet recruiting, 3 recruiting, 1 enrolling by invitation. 15 Phase 2, 2 Phase 3, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 215Completed 7, Not yet recruiting 4, Recruiting 3, Enrolling by invitation 1
Phase 32Completed 1, Recruiting 1
Phase 11Recruiting 1

Follow Posttraumatic Stress Disorder (PTSD): new trials by email Literature Review of Posttraumatic Stress Disorder (PTSD) trials Research Report on Posttraumatic Stress Disorder (PTSD)

Trials (filtered) newest first · largest first

All 15 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Enhancing the Effect of Stellate Ganglion Block in the Treatment of PTSD: Bupivacaine vs Bupivacaine + Ketamine
SGB - Combined Solution of Bupivacaine + Saline, SGB - Combined Solution of Bupivacaine + Ketamine Adjuvant - Posttraumatic Stress Disorder (PTSD)
Phase 2Not yet recruitingThe Royal's Institute of Mental Health Research1262027-02-012026-11-16
Psilocybin-Assisted Psychotherapy for Veterans With PTSD
Psilocybin-assisted Psychotherapy - Posttraumatic Stress Disorder (PTSD)
Phase 2Not yet recruitingARQ National Psychotrauma Centre122026-12-012026-08-28
MDMA-AT for PTSD in Young Adults With Childhood Trauma
MDMA assisted psychotherapy - Posttraumatic Stress Disorder (PTSD)
Phase 2Not yet recruitingJenna M. Traynor152026-10-312026-08-20
Post-traumatic Estradiol Administration and Care Evaluation (PEACE)
17β-estradiol, Placebo - Chronic Musculoskeletal Pain, Sexual Assault
Phase 2Not yet recruitingUniversity of North Carolina, Chapel Hill302026-09-282026-10-09
The Many Roads to Trauma Recovery: A Clinical Trial Comparing Empirically Supported Treatments for Veterans With Co-Morbid Posttraumatic Stress and Substance Use Disorder Symptoms
Trauma Informed Heart Rate Variability Biofeedback, Present Centered Therapy - Posttraumatic Stress Disorder (PTSD), Substance Use Disorder (SUD)
Phase 2 / Phase 3RecruitingCoatesville VA Medical Center502026-08-012026-08-11
Ketamine Assisted Psychotherapy for Treating Comorbid Chronic Pain and PTSD
Ketamine Infusion, Mindfulness-based cognitive therapy - Chronic Pain, Posttraumatic Stress Disorder (PTSD)
Phase 1 / Phase 2RecruitingDr. Yuliya Knyahnytska302026-03-312026-09-15
Ayahuasca, Esketamine and PTSD
Ayahuasca, Esketamine - Posttraumatic Stress Disorder (PTSD)
Phase 2RecruitingUniversity of Sao Paulo102025-12-202026-01-05
A Study to Evaluate Effects on Sleep and Safety of RE03 in PTSD Patients With Sleep Disturbances
RE03, Placebo - Posttraumatic Stress Disorder (PTSD), Sleep Disturbances and Insomnia
Phase 2CompletedReconnect Labs122025-09-302026-07-23
High-Intensity Inpatient MDMA-Assisted Psychotherapy for PTSD
High-intensity inpatient MDMA-assisted psychotherapy - Posttraumatic Stress Disorder (PTSD)
Phase 2Enrolling by invitationARQ National Psychotrauma Centre202025-05-162025-07-24
NAC for Treating Comorbid PTSD and SUD
N-acetylcysteine, Placebo, Cognitive behavioral therapy - Posttraumatic Stress Disorder (PTSD), Alcohol Use Disorder (AUD)
Phase 2CompletedMedical University of South Carolina902016-10-012021-05-19
Oxytocin and Affect Processing in Posttraumatic Stress Disorder
Oxytocin, Placebo - Posttraumatic Stress Disorder (PTSD)
Phase 2CompletedYale University112015-08-012020-04-08
Ketamine as a Treatment for Post-Traumatic Stress Disorder (PTSD)
Ketamine, Midazolam - Posttraumatic Stress Disorder (PTSD)
Phase 2 / Phase 3CompletedIcahn School of Medicine at Mount Sinai302015-05-182021-03-11
Prazosin and Naltrexone (PaN) Study for Veterans With Alcohol Use Disorders
Prazosin, Naltrexone, Placebo (Prazosin) - Alcohol Use Disorder, Posttraumatic Stress Disorder (PTSD)
Phase 2CompletedSeattle Institute for Biomedical and Clinical Research312015-03-032020-12-29
Randomized, Double-blind, Placebo-Controlled Pilot Study of MDMA-assisted Therapy for PTSD
Active Placebo Dose MDMA-assisted therapy (25 mg), Full Dose MDMA-assisted therapy (125 mg), Open-Label Full Dose MDMA-assisted therapy (125 mg) - Posttraumatic Stress Disorder (PTSD)
Phase 2CompletedResilient Pharmaceuticals102013-01-172025-06-06
DElivery of Self Training and Education for Stressful Situations-Primary Care Version
DESTRESS-PC, Optimized Usual Primary Care PTSD treatment - Posttraumatic Stress Disorder (PTSD)
Phase 2CompletedHenry M. Jackson Foundation for the Advancement of Military Medicine1332008-05-012012-01-12

Narrower conditions

Stress Disorders, Post-Traumatic (15)  ·  Substance-Related Disorders (3)  ·  Wounds and Injuries (3)  ·  Alcoholism (2)  ·  Chronic Pain (2)  ·  Alcohol Drinking (1)  ·  Behavior, Addictive (1)  ·  Drinking Behavior (1)  ·  Parasomnias (1)  ·  Sleep Initiation and Maintenance Disorders (1)

Broader conditions

Mental Disorders (15)  ·  Stress Disorders, Traumatic (15)  ·  Trauma and Stressor Related Disorders (15)  ·  Chemically-Induced Disorders (3)  ·  Alcohol-Related Disorders (2)  ·  Neurologic Manifestations (2)  ·  Pain (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Signs and Symptoms (2)  ·  Behavior (1)  ·  Compulsive Behavior (1)  ·  Dyssomnias (1)  ·  Impulsive Behavior (1)  ·  Nervous System Diseases (1)  ·  Sleep Disorders, Intrinsic (1)

Interventions

Sodium Chloride (2)  ·  Acetylcysteine (1)  ·  Bupivacaine (1)  ·  Cognitive Behavioral Therapy (1)  ·  Esketamine (1)  ·  Estradiol (1)  ·  Ketamine (1)  ·  Midazolam (1)  ·  Mindfulness-Based Cognitive Therapy (1)  ·  N-Methyl-3,4-methylenedioxyamphetamine (1)  ·  Naltrexone (1)  ·  Oxytocin (1)  ·  Prazosin (1)  ·  Psychotherapy (1)

Sponsors

ARQ National Psychotrauma Centre (2)  ·  Coatesville VA Medical Center (1)  ·  Dr. Yuliya Knyahnytska (1)  ·  Henry M. Jackson Foundation for the Advancement of Military Medicine (1)  ·  Icahn School of Medicine at Mount Sinai (1)  ·  Jenna M. Traynor (1)  ·  Medical University of South Carolina (1)  ·  Reconnect Labs (1)  ·  Resilient Pharmaceuticals (1)  ·  Seattle Institute for Biomedical and Clinical Research (1)  ·  The Royal's Institute of Mental Health Research (1)  ·  University of North Carolina, Chapel Hill (1)  ·  University of Sao Paulo (1)  ·  Yale University (1)

Countries

United States (7)  ·  Canada (2)  ·  Netherlands (2)  ·  Brazil (1)  ·  Israel (1)  ·  Switzerland (1)

Top investigators

Adriana Feder, MD (1)  ·  Andres Ort, MD (1)  ·  Charles C. Engel, M.D., M.P.H. (1)  ·  Eric Vermetten, MD, PhD (1)  ·  Jenna M Traynor (1)  ·  Jennifer Tang, MD, MSCR (1)  ·  Linda Mayes, MD (1)  ·  Moshe Kotler (1)  ·  Rebecca J Gomez, MD (1)  ·  Sarah Linnstaedt, PhD (1)  ·  Sudie Back, Ph.D. (1)  ·  Tracy Simpson, Ph.D. (1)

Results publications

PMID 31572236, PMID 29441152, PMID 30013726, PMID 31065731, PMID 32500209, PMID 33397139, PMID 33972795, PMID 34015141, PMID 37709999

NIH funding

2025 (1), R34MH078874 (1)